超声造影联合定量分析参数对炎症性肠病活动性诊断及治疗的临床指导价值

倪娟娟; 孙医学; 石彦; 李阳; 朱玉

doi:10.16766/j.cnki.issn.1674-4152.002953

超声造影联合定量分析参数对炎症性肠病活动性诊断及治疗的临床指导价值

doi: 10.16766/j.cnki.issn.1674-4152.002953

蚌埠医学院第一附属医院超声医学科，安徽蚌埠 233004

基金项目:

安徽省高校自然科学研究项目 KJ2020A0582

详细信息

通讯作者:
孙医学，E-mail：13309621158@163.com

中图分类号: R445.1 R574.62
计量
- 文章访问数: 180
- HTML全文浏览量: 36
- PDF下载量: 4
- 被引次数: 0
出版历程
- 收稿日期: 2022-08-23
- 网络出版日期: 2023-05-31

Contrast-enhanced ultrasound combined quantitative analysis of the parameters of clinical guidance value in the diagnosis and treatment of inflammatory bowel disease activity

Department of Ultrasound Medicine, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China

摘要

摘要: 目的研究联合应用超声造影(CEUS)及定量分析参数对炎症性肠病(IBD)炎症活动性的诊断效果。方法选择2021年11月—2022年8月蚌埠医学院第一附属医院消化内科收治的住院IBD患者以及门诊随诊的IBD患者共27例，结合病理及临床诊断分成溃疡性结肠炎(UC组，13例)及克罗恩病(CD组，14例)，依据CD活动指数评分表及改良Mayo量表，分别将2组患者分为活动组与非活动组，再分别比较活动组与非活动组患者肠壁的厚度，能量多普勒(PDI)血流情况、CEUS强化模式及定量参数[峰值强度(PI)、上升支斜率(AS)、到达时间(AT)、达峰时间(TTP)]。结果溃疡性结肠炎活动组患者的肠壁厚度均高于非活动组[(8.4±1.3)mm vs. (5.2±1.0)mm，t=4.810，P=0.001]，克罗恩病活动组患者的肠壁厚度均高于非活动组[(8.2±1.8)mm vs. (5.1±1.2)mm，t=3.850，P=0.002]。溃疡性结肠炎活动与非活动组患者肠壁血流分级及CEUS强化模式比较差异有统计学意义(均P＜0.05)。溃疡性结肠炎活动与非活动组患者PI、AT比较差异有统计学意义(均P＜0.05)；克罗恩病活动与非活动组患者PI、TTP比较差异有统计学意义(均P＜0.05)。结论肠壁厚度、PDI、CEUS强化方式及定量参数PI、AT、TTP均与炎症性肠病活动性的诊断与评估相关。
- 超声检查 /
- 超声增强 /
- 炎症性肠病 /
- 定量参数
Abstract: Objective To study the effectiveness of the combined use of contrast-enhanced ultrasound (CEUS) and quantitative analysis parameters for the diagnosis of inflammatory bowel disease (IBD) in terms of inflammatory activity. Methods A total of 27 inpatients with IBD admitted to the Department of Gastroenterology of the First Affiliated Hospital of Bengbu Medical College and the outpatient follow-up IBD patients were selected from November 2021 to August 2022. They were divided into ulcerative colitis (UC group, 13 cases) and Crohn ' s disease (CD group, 14 cases) groups according to their pathology and clinical diagnosis. According to the CD activity index score and the modified Mayo scale, the two groups of patients were divided into active and inactive groups. Intestinal wall thickness, power Doppler image (PDI) blood flow, CEUS enhancement mode and quantitative parameters [peak intensity (PI), ascending slope (AS), arrival time (AT), time to peak (TTP)] were compared between active and inactive groups. Results The intestinal wall thickness in the active group of UC was greater than that in the inactive group [(8.4±1.3) mm vs. (5.2±1.0) mm, t=4.810, P=0.001]. The intestinal wall thickness in the active group of CD was greater than that in the inactive group [(8.2±1.8) mm vs. (5.1±1.2) mm, t=3.850, P=0.002]. There were significant differences in the grading of intestinal wall blood flow and the enhancement pattern of CEUS between the active and inactive UC groups (all P < 0.05). There were significant differences in PI and AT between the active and inactive UC groups (both P < 0.05). There were significant differences in PI and TTP between the active and inactive CD groups (both P < 0.05). Conclusion The intestinal wall thickness, PDI, CEUS enhancement pattern and the quantitative analysis parameters PI, AT and TTP are all relevant to the diagnosis and assessment of inflammatory bowel disease activity.
- Ultrasound /
- Contrast agents /
- Inflammatory bowel disease /
- The quantitative parameters

HTML全文

表 1 活动与非活动组炎症性肠病患者性别比较[例(%)]

Table 1. Comparison of gender between active and inactive groups in patients with inflammatory bowel disease[cases(%)]

组别	例数	性别		P值
组别	例数	男性	女性	P值
溃疡性结肠炎	13			0.500
活动组	8	3(37.5)	5(62.5)
非活动组	5	5(100.0)	0
克罗恩病	14			0.833
活动组	8	4(50.0)	4(50.0)
非活动组	6	5(83.3)	1(16.7)
注：采用Fisher精确检验。

下载: 导出CSV

表 2 活动与非活动组炎症性肠病患者肠壁厚度比较(x±s, mm)

Table 2. Comparison of intestinal wall thickness between active and inactive groups in patients with inflammatory bowel disease(x±s, mm)

组别	例数	肠壁厚度	t值	P值
溃疡性结肠炎	13		4.810	0.001
活动组	8	8.4±1.3
非活动组	5	5.2±1.0
克罗恩病	14		3.850	0.002
活动组	8	8.2±1.8
非活动组	6	5.1±1.2

下载: 导出CSV

表 3 活动与非活动组炎症性肠病患者肠壁血流分级情况比较[例(%)]

Table 3. Comparison of grading of intestinal wall blood flow in active and inactive groups of patients with inflammatory bowel disease [cases(%)]

组别	例数	肠壁血流情况		P值
组别	例数	0~1级	2~3级	P值
溃疡性结肠炎	13			0.007
活动组	8	0	8(100.0)
非活动组	5	4(80.0)	1(20.0)
克罗恩病	14			0.090
活动组	8	1(12.5)	7(87.5)
非活动组	6	4(66.7)	2(33.3)
注：采用Fisher精确检验。

下载: 导出CSV

表 4 活动与非活动组炎症性肠病患者肠壁超声造影增强模式比较[例(%)]

Table 4. Enhanced mode of contrast-enhanced ultrasonography of intestinal wall in patients with inflammatory bowel disease at active and inactive stages[cases(%)]

组别	例数	肠壁增强方式		P值
组别	例数	黏膜及黏膜下层增强	全层增强	P值
溃疡性结肠炎	13			0.005
活动组	8	1(12.5)	7(87.5)
非活动组	5	5(100.0)	0
克罗恩病	14			0.100
活动组	8	2(25.0)	6(75.0)
非活动组	6	5(83.3)	1(16.7)
注：采用Fisher精确检验。

下载: 导出CSV

表 5 活动与非活动组炎症性肠病患者肠壁超声定量参数比较(x±s)

Table 5. Comparison of ultrasonic quantitative parameters of intestinal wall in active and inactive inflammatory bowel patients(x±s)

组别	例数	PI(dB)	AT(s)	TTP(s)	AS(dB/s)
溃疡性结肠炎	13
活动组	8	32.2±3.6	16.9±2.7	30.9±3.6	1.9±0.6
非活动组	5	22.8±3.7	22.1±4.1	32.4±3.4	1.7±0.2
t值		4.490	2.520	0.774	0.860
P值		0.002	0.040	0.501	0.400
克罗恩病	14
活动组	8	33.3±2.6	18.8±6.1	29.7±5.5	1.6±0.3
非活动组	6	27.9±3.7	24.0±4.0	38.6±5.7	1.2±0.4
t值		3.124	1.901	2.910	1.860
P值		0.020	0.070	0.010	0.090

下载: 导出CSV

参考文献(21)

[1]	陈瑜君, 陈淑玲, 谢晓燕. 胃肠道超声在炎症性肠病中的应用与新进展[J]. 中华炎性肠病杂志, 2019, 3(4): 313-315. CHEN Y J, CHEN S L, XIE X Y. Applications and progress of gastrointestinal ultrasound in inflammatory bowel disease[J]. Chinese Journal of Inflammatory Bowel Diseases, 2019, 3(4): 313-315.
[2]	西永忠. 腹部超声在炎性肠病活动期中的诊断价值[J]. 中国肛肠病杂志, 2019, 39(10): 25-26. https://www.cnki.com.cn/Article/CJFDTOTAL-GCBZ201910013.htm XI Y Z. The Value of Abdominal Ultrasonograpy in Diagnosing Active Stage of Inflammatory Bowel Disease[J]. Chinese Journal of Coloproctology, 2019, 39(10): 25-26. https://www.cnki.com.cn/Article/CJFDTOTAL-GCBZ201910013.htm
[3]	吴越, 陈秋雨, 陈中霞, 等. 经腹肠道超声在炎症性肠病诊断与评估中的应用和进展[J]. 胃肠病学, 2021, 26(1): 57-61. https://www.cnki.com.cn/Article/CJFDTOTAL-WIEC202101011.htm WU Y, CHEN Q Y, CHEN Z X, et al. Application and Progress of Trans-abdominal Bowel Ultrasound for Diagnosis and Assessment of Inflammatory Bowel Disease[J]. Chinese Journal of Gastroenterology, 2021, 26(1): 57-61. https://www.cnki.com.cn/Article/CJFDTOTAL-WIEC202101011.htm
[4]	瞿庆红, 陈霞. 经腹彩色多普勒超声检查在溃疡性结肠炎早期诊断和活动性评估中的应用价值[J]. 中国现代医生, 2019, 57(8): 122-125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201908036.htm QU Q H, CHEN X. Application value of transabdominal color Doppler ultrasound in early diagnosis and activity evaluation of ulcerative colitis[J]. China Modern Doctor, 2019, 57(8): 122-125. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201908036.htm
[5]	王韦力, 程文捷, 文艳玲, 等. 超声造影定量分析评估克罗恩病炎症活动程度的应用价值[J]. 中华医学超声杂志(电子版), 2019, 16(12): 949-955. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHCD201912012.htm WANG W L, CHENG W J, WEN Y L, et al. Contrast-enhanced ultrasound quantitative analysis for assessment of disease activity of Crohn′s disease[J]. Chinese Journal of Medical Ultrasound Celectronic Edition, 2019, 16(12): 949-955. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHCD201912012.htm
[6]	MEDELLIN A, MERRILL C, WILSON S R. Role of contrast-enhanced ultrasound in evaluation of the bowel[J]. Abdom Radiol(NY), 2018, 43(4): 918-933.
[7]	MACONI G, NYLUND K, RIPOLLES T, et al. EFSUMB recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in inflammatory bowel diseases [J]. Ultraschall Med, 2018, 39(3): 304-317. http://europepmc.org/abstract/MED/29566419
[8]	AHMED R, DEBIAN H, FAWZI M, et al. Diagnosis of inflammatory bowel disease by abdominal ultrasound and color Doppler techniques[J]. Curr Med Imaging, 2021, 17(9): 1085-1093. http://pubmed.ncbi.nlm.nih.gov/33397243/
[9]	SMITH R L, TAYLOR K M, FRIEDMAN A B, et al. Systematic review: clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis[J]. J Crohns Colitis, 2020, 14(4): 465-479. http://pubmed.ncbi.nlm.nih.gov/31562739/
[10]	丁诗思, 刘畅, 徐辉雄. 克罗恩病超声诊断的现状及进展[J]. 中华医学超声杂志(电子版), 2020, 17(10): 927-932. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHCD202010002.htm DING S S, LIU C, XU H X. Status quo and progress of ultrasound diagnosis of Crohn's disease[J]. Chinese Journal of Medical Ultrasound Celectronic Edition, 2020, 17(10): 927-932. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHCD202010002.htm
[11]	王海燕, 朱林林, 周如海, 等. 超声造影定量分析诊断乳头状甲状腺癌患者颈部淋巴结转移的效能分析[J]. 中华全科医学, 2019, 17(12): 2079-2082. doi: 10.16766/j.cnki.issn.1674-4152.001132 WANG H Y, ZHU L L, ZHOU R H, et al. Effectiveness of contrast-enhanced ultrasound quantitative analysis in the diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma[J]. Chinese Journal of General Practice, 2019, 17(12): 2079-2082. doi: 10.16766/j.cnki.issn.1674-4152.001132
[12]	BETTENWORTH D, BOKEMEYER A, BAKER M, et al. Assessment of Crohn ' s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review[J]. Gut, 2019, 68(6): 1115-1126. http://www.xueshufan.com/publication/2927147343
[13]	于叶民, 顾林, 燕善军, 等. 溃疡性结肠炎患者JAM-1蛋白与STAT3信号通路关系的研究[J]. 中华全科医学, 2019, 17(3): 370-373. doi: 10.16766/j.cnki.issn.1674-4152.000684 YU Y M, GU L, YAN S J, et al. Relationship between JAM-1 and STAT3 signaling pathway in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2019, 17(3): 370-373. doi: 10.16766/j.cnki.issn.1674-4152.000684
[14]	WILKENS R, HAGEMANN-MADSEN R H, PETERS D A, et al. Validity of contrast-enhanced ultrasonography and dynamic contrast-enhanced mr enterography in the assessment of transmural activity and fibrosis in Crohn ' s disease [J]. J Crohns Colitis, 2018, 12(1): 48-56.
[15]	GABBIADINI R, ZACHAROPOULOU E, FURFARO F, et al. Application of ultrasound elastography for assessing intestinal fibrosis in inflammatory bowel disease: fiction or reality?[J]. Curr Drug Targets, 2021, 22(3): 347-355. http://pubmed.ncbi.nlm.nih.gov/33213341/
[16]	CELIKYAY F, YUKSEKKAYA R, YUKSEKKAYA M, et al. Color doppler ultrasound assessment of clinical activity in inflammatory bowel disease[J]. Curr Med Imaging, 2021, 17(6): 741-750. http://www.researchgate.net/publication/348046426_Color_Doppler_Ultrasound_Assessment_of_Clinical_Activity_in_Inflammatory_Bowel_Disease
[17]	ZHANG F, MIAO L Y, GE H Y, et al. Usefulness of contrast-enhanced ultrasound in differentiating inflammatory bowel disease from colon cancer [J]. Ultrasound Med Biol, 2018, 44(1): 124-133.
[18]	KUNZE G, SEITZ K, MAUCH M, et al. Clinical ultrasound in inflammatory bowel disease[J]. Ultraschall Med, 2019, 40(2): 132-162.
[19]	HA C W Y, MARTIN A, SEPICH-POORE G D, et al. Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans[J]. Cell, 2020, 183(3): 666-683. http://www.xueshufan.com/publication/3088648928
[20]	GRAHAM D B, XAVIER R J. Pathway paradigms revealed from the genetics of inflammatory bowel disease[J]. Nature, 2020, 578(7796): 527-539. doi: 10.1038/s41586-020-2025-2
[21]	黄蓉, 曹莞婷, 范一宏, 等. 超声技术对炎症性肠病诊断的研究进展[J]. 中华超声影像学杂志, 2021, 30(4): 362-368. HUANG R, CAO G T, FAN Y H, et al. Progress in the diagnosis of inflammatory bowel disease by ultrasonography technique[J]. Chinese Journal of Ultrasonography, 2021, 30(4): 362-368.